NCR Atleos Corp
NATL NYSE Calculating & Accounting Machines (No Electronic Computers) Financials FY2021βFY2025
What NCR Atleos Corp does
No business description yet.
- Legal name
- NCR Atleos Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001628280-26-012576
0001974138
Revenue and margins
NCR Atleos Corp had $4.4B of revenue in fiscal 2025, up 1.1% on the year before.
Net income and earnings per share
From fiscal 2021 to 2025, diluted EPS grew β5.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $239M in fiscal 2025, 5.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
NCR Atleos Corp returned $28.0M to shareholders in fiscal 2025, 12% of free cash flow. The diluted share count rose 1.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably NCR Atleos Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $238M | $293M | $339M | $419M | $456M |
| Debt incl. finance leases | β | $825M | $3.2B | $2.9B | $2.8B |
| Net debt / EBITDA | β | 1.4x | 5.5x | 3.5x | 3.1x |
| Debt / equity | β | 0.3x | 14.5x | 13.4x | 6.8x |
| Interest coverage | β | 8.3x | 2.9x | 1.4x | 1.8x |
| Current ratio | β | 1.2x | 1.0x | 1.0x | 1.0x |
| Quick ratio | β | 0.9x | 0.9x | 0.8x | 0.8x |
| Total assets | β | $5.8B | $5.7B | $5.5B | $5.7B |
| Total liabilities | β | $2.5B | $5.5B | $5.3B | $5.3B |
| Shareholders' equity | $2.3B | $3.3B | $219M | $219M | $403M |
| Net debt (β = net cash) | β | $532M | $2.8B | $2.5B | $2.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β | β3.0% | β8.8% | β4.7% | β3.5% |
| Altman Z'' | β | 1.98 | 0.52 | 0.72 | 0.73 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.5B | $4.1B | $4.2B | $4.3B | $4.4B |
| Net interest income | β$49.0M | β$31.0M | β$90.0M | β | β |
| Research and development | $107M | $64.0M | $80.0M | $62.0M | $70.0M |
| Operating income | $248M | $258M | $263M | $437M | $478M |
| Interest expense | β | $31.0M | $90.0M | $309M | $270M |
| Pretax income | $251M | $146M | $89.0M | $125M | $189M |
| Income tax | $64.0M | $48.0M | $237M | $44.0M | $27.0M |
| Net income | $186M | $99.0M | β$150M | $80.0M | $162M |
| Diluted EPS | $2.63 | $1.40 | β$2.12 | $1.08 | $2.14 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.08B |
| Cash flow | |||||
| Cash from operations | $449M | $274M | $355M | $344M | $356M |
| Capital expenditure | $80.0M | $58.0M | $108M | $87.0M | $117M |
| Free cash flow | $369M | $216M | $247M | $257M | $239M |
| Depreciation and amortization | $72.0M | $127M | $254M | $287M | $277M |
| Stock-based compensation | $82.0M | $66.0M | $68.0M | $38.0M | $34.0M |
| Acquisitions | $2.3B | $78.0M | $1.0M | $0.0M | $17.0M |
| Share buybacks | β | β | $0.0M | $0.0M | $28.0M |
| Dividends and buybacks | β | β | $0.0M | $0.0M | $28.0M |
| Balance sheet | |||||
| Cash and short-term investments | $238M | $293M | $339M | $419M | $456M |
| Total debt | β | $825M | $3.2B | $2.9B | $2.8B |
| Finance lease liabilities | β | β | $2.0M | $7.0M | $14.0M |
| Current assets | β | $1.6B | $1.9B | $1.7B | $1.8B |
| Current liabilities | β | $1.4B | $1.8B | $1.7B | $1.9B |
| Inventory | β | $419M | $333M | $307M | $342M |
| Property and equipment, net | β | $412M | $468M | $474M | $511M |
| Goodwill | $1.9B | $1.9B | $2.0B | $2.0B | $2.0B |
| Intangible assets | β | $729M | $635M | $550M | $498M |
| Total assets | β | $5.8B | $5.7B | $5.5B | $5.7B |
| Total liabilities | β | $2.5B | $5.5B | $5.3B | $5.3B |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.3B | $3.3B | $219M | $219M | $403M |
| Margins | |||||
| Operating margin | 7.0% | 6.3% | 6.3% | 10.2% | 11.0% |
| EBITDA margin | 9.0% | 9.3% | 12.4% | 16.8% | 17.3% |
| Net margin | 5.2% | 2.4% | β3.6% | 1.9% | 3.7% |
| FCF margin | 10.4% | 5.2% | 5.9% | 6.0% | 5.5% |
| Net interest share of revenue | β1.4% | β0.8% | β2.2% | β | β |
| Returns | |||||
| Return on capital | β | 4.6% | 5.6% | 10.4% | 15.1% |
| Return on capital employed | β | 5.9% | 6.7% | 11.5% | 12.7% |
| Return on equity | 8.0% | 3.5% | β8.6% | 36.5% | 52.1% |
| Return on assets | β | 1.7% | β2.6% | 1.4% | 2.9% |
| Return on tangible equity | 43.6% | 16.9% | β | β | β |
| Growth | |||||
| Revenue growth | β | 16.1% | 1.6% | 2.8% | 1.1% |
| Net income growth | β | β46.8% | β251.5% | β | 102.5% |
| EPS growth | β | β46.8% | β251.4% | β | 98.1% |
| FCF growth | β | β41.5% | 14.4% | 4.0% | β7.0% |
| Share count change | β | 0.0% | 0.0% | 5.1% | 1.9% |
| Financial health | |||||
| Net debt / EBITDA | β | 1.4x | 5.5x | 3.5x | 3.1x |
| Debt / equity | β | 0.3x | 14.5x | 13.4x | 6.8x |
| Interest coverage | β | 8.3x | 2.9x | 1.4x | 1.8x |
| Current ratio | β | 1.2x | 1.0x | 1.0x | 1.0x |
| Quick ratio | β | 0.9x | 0.9x | 0.8x | 0.8x |
| Capital allocation | |||||
| Capex / revenue | 2.3% | 1.4% | 2.6% | 2.0% | 2.7% |
| Stock comp / revenue | 2.3% | 1.6% | 1.6% | 0.9% | 0.8% |
| Payouts / FCF | β | β | 0.0% | 0.0% | 11.7% |
| Quality scores | |||||
| Piotroski F-score | β | β | 4.0 | 6.0 | 5.0 |
| Altman Z'' | β | 2.0 | 0.5 | 0.7 | 0.7 |
| Accruals ratio | β | β3.0% | β8.8% | β4.7% | β3.5% |
Source: SEC EDGAR XBRL filings (CIK 0001974138). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.